Lazarex Cancer Foundation

What Lazarex Cancer Foundation does

Lazarex Cancer Foundation is a U.S.-based nonprofit organization founded in 2006 and headquartered in Danville, California, that improves outcomes in cancer care by reducing financial and informational barriers to clinical trial participation for advanced-stage cancer patients. Its core program, IMPACT (Improving Patient Access to Cancer Clinical Trials), deploys on-site coordinators at 20 National Comprehensive Cancer Centers — including USC Norris — to educate eligible patients on FDA-approved clinical trials as viable treatment options and provide financial assistance for trial participation. The foundation complements this with the NeighborGood program, a community-based initiative that partners with Vision y Compromiso to engage Promotores de Salud in clinical trial education at the community level, and co-develops targeted multilingual and multicultural interventions (such as the Sailors Project for Hispanic and Korean American patients at LAC+USC Medical Center).

Operationally, Lazarex runs a lean team of 11–50 employees and works through institutional partnerships rather than direct-to-consumer channels. Its business model is donation-funded: revenue derives from charitable contributions and institutional partnerships (e.g., Tower Cancer Research Foundation funds the Ronnie Lippin Cancer Support and Navigation Program at USC Norris in partnership with the Lippin Family). No pricing model applies as services are provided free of charge to patients, and the foundation does not disclose technology infrastructure, proprietary platforms, or AI/ML capabilities.

The foundation's strategic posture centers on deepening institutional alliances with NCI-designated cancer centers, expanding community-based outreach to underserved populations, and extending services across the cancer care continuum from prevention through treatment. Geographic operations are confined to the United States, and growth is organic rather than capital-financed — no funding rounds, acquisitions, or leadership changes are disclosed in the available data.

Name

Lazarex Cancer Foundation

Legal name

Lazarex Cancer Foundation

Website

https://lazarex.org

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

Lazarex Cancer Foundation is a U.S. nonprofit founded in 2006 that provides financial assistance and patient education to help advanced-stage cancer patients access FDA-approved clinical trials, operating on-site at 20 National Comprehensive Cancer Centers and through community health worker partnerships.

Ownership category

akta.pro rank

Product category

Nonprofit Cancer Patient Support Services

NAICS

Individual and Family Services (6241), Social Assistance (624)

SIC

Services-Social Services (8300), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

akta.pro secondary industries

Health & Medical Research Grantmaking Foundations (BPAGAKAL), Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM), Clinical Trial Site Operations & Study Coordination (HLAGACAE)

Keywords

• Cancer clinical trials
• Patient financial assistance
• Nonprofit cancer support
• Community health outreach
• Patient navigation services

Headquarters

HQ city

Danville

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Others, Marketing or Sales

Revenue model

1. Donations and Charitable Contributions: As a non-profit foundation, Lazarex Cancer Foundation operates primarily through charitable donations and contributions from donors to provide financial assistance to advanced-stage cancer patients participating in clinical trials.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Lazarex Cancer Foundation provides financial assistance and patient education to advanced-stage cancer patients who want to participate in FDA-approved clinical trials. Through its IMPACT (Improving Patient Access to Cancer Clinical Trials) program, on-site coordinators at 20 national comprehensive cancer centers educate eligible patients on open trials, how and why they are conducted, and how clinical trials can be viable treatment options. The NeighborGood community-based program extends this mission by engaging community health workers (Promotores de Salud) to educate individuals about clinical trials at the community level, addressing the continuum of cancer care from prevention through treatment.

Product overview

Lazarex Cancer Foundation operates as a financial assistance and patient support organization rather than a technology product company. The core offering is the IMPACT program (Improving Patient Access to Cancer Clinical Trials), which provides financial assistance to advanced-stage cancer patients who want to participate in FDA-approved clinical trials. The program includes patient education on clinical trials as viable treatment options. USC Norris is one of 20 national comprehensive cancer centers facilitating the IMPACT program on-site.

Differentiator

Problem solved

Functional benefit

Brands

• IMPACT (Improving Patient Access to Cancer Clinical Trials): Program through which coordinators educate eligible patients on open clinical trials, how and why they are conducted, and how they can be viable treatment options.
• NeighborGood

Products and services

• IMPACT (Improving Patient Access to Cancer Clinical Trials)

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core and flagship.

• USC Norris Comprehensive Cancer CentercoreStrategic or Co-development PartnerUSC Norris supports Lazarex Cancer Foundation's mission and is one of 20 national comprehensive cancer centers currently facilitating the IMPACT (Improving Patient Access to Cancer Clinical Trials) program on-site. The partnership involves an on-site program coordinator who educates eligible patients on open trials, how and why they are conducted, and how they can be viable treatment options.
• Vision y Compromiso (Network of Community Health Workers)coreStrategic or Co-development PartnerThrough the NeighborGood program, Lazarex partners with Vision y Compromiso, a network of over 5,000 community health workers (Promotores de Salud) who meet annually bringing together over 900 promotores each year. This partnership enables clinical trial education at the community level.
• Tower Cancer Research FoundationflagshipStrategic or Co-development PartnerThe Ronnie Lippin Cancer Support and Navigation Program at USC Norris is funded by Tower Cancer Research Foundation (TCRF), in partnership with the Lippin Family. This program provides cancer patient lay navigation services that complement Lazarex's mission of helping patients access clinical trials.

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Direct peers

• Patient Advocate Foundation: National nonprofit providing direct financial aid and case management to patients with chronic and life-threatening illnesses, including cancer. Highly comparable mission and service model to Lazarex, with a broader disease scope.
• HealthWell Foundation: Independent nonprofit that reduces financial barriers to care by covering copays, premiums, and treatment-related costs for underinsured patients, including cancer patients. Directly comparable financial-assistance model.
• PAN Foundation: National charitable foundation providing underinsured patients with financial assistance for out-of-pocket medical costs, including cancer treatment and clinical-trial-related expenses. Closest functional competitor in copay/trial-support.
• CISCRP (Center for Information & Study on Clinical Research Participation): Nonprofit focused on educating the public and patients about clinical trial participation. Closely comparable education-and-awareness mission to Lazarex's IMPACT program, though without the financial-assistance component.

Broad incumbents

• American Cancer Society: Largest U.S. cancer-focused nonprofit, offering patient services including Road To Recovery (transportation) and Hope Lodge (lodging) that overlap with Lazarex's trial-travel assistance. Operates at vastly larger scale.
• National Cancer Institute: Federal agency funding cancer research and operating the clinicaltrials.gov registry. Indirectly overlaps with Lazarex's trial-access mission but as a government incumbent with vastly broader scope and resources.
• The Leukemia & Lymphoma Society: Large disease-specific nonprofit funding blood-cancer research and providing patient financial assistance and navigation. Comparable in mission but specialized to hematologic malignancies.

Emerging players

• EmergingMed: Clinical trial matching and navigation service used by sponsors and cancer centers. Competes with the patient-matching layer of Lazarex's IMPACT program through a technology-enabled approach.
• Antidote (formerly TrialReach): Digital patient-recruitment platform for clinical trials, competing with the education and trial-matching portion of Lazarex's service offering through algorithmic matching.

Others

• Tower Cancer Research Foundation: Regional nonprofit funding cancer research and patient-support programs in Southern California, including the Ronnie Lippin Navigation Program that complements Lazarex's IMPACT at USC Norris. A current partner and ecosystem ally.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lazarex Cancer Foundation